Texas
-
3 ways to reform the pharmacy benefits industry
At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.
-
Register for MedCity INVEST Digital Health and take part in a discussion on pharmacy benefit management
The MedCity INVEST Digital Health conference in Dallas September 28 in collaboration with Health Wildcatters marks our first conference in the Lone Star state and new themes embracing employee benefits and the financial experience in healthcare. Register today!
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Texas sues HHS, claims the agency is trying to turn ERs into abortion clinics
The attorney general of Texas says the recent federal mandates and guidance issued to healthcare providers to protect abortion access are unconstitutional and conflict with state law.
-
Metaverse in healthcare
Dr. Mona Flores, Global Head of Medical AI at Nvidia, will deliver the keynote talk kicking off the MedCity INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented in collaboration with Health Wildcatters. Register today.
-
FDA rejects Reata Pharma chronic kidney disease drug; new trial needed
The FDA told Reata that the clinical data do not show that the drug, bardoxolone, slows the progression of the loss of kidney function in patients who have the rare disease Alport syndrome. The regulatory decision follows an FDA advisory committee vote recommending against approval of the small molecule drug.
-
Justice Department sues Texas to block restrictive abortion law
The Biden administration has issued a legal challenge to invalidate the controversial Texas law that bans abortions after six weeks of pregnancy claiming that it will strip residents of their constitutional rights.
-
Walgreens shares next step in primary care plans: 29 more clinics in Texas
As part of a partnership with primary care provider VillageMD, Walgreens plans to open 29 clinics in Texas this year. In total, the companies plan to open at least 600 clinics over the next four years.
-
Texas lawsuit: Biden administration threatening funding to force Medicaid expansion
Filed by the Texas attorney general, a new lawsuit seeks to prevent the Biden administration from revoking the Trump-era approval of a Medicaid waiver extension that could cost the state billions in funds. The revocation was a political move intended to force the state to expand Medicaid under the ACA, the lawsuit claims.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
HHS issues HIPAA, CMS regulatory waivers to Texas hospitals
As Texas reels from a devasting winter storm, HHS is issuing several waivers to help hospitals continue to provide care amid mounting challenges. These waivers allow non-compliance with certain HIPAA provisions and other federal regulations.
-
Doctor On Demand, Community Health Choice launch virtual primary care plan in Texas
The telehealth company and managed care organization are launching a new HMO plan on the Texas health insurance exchange. The ‘virtual-first’ plan is designed for those who do not qualify for Medicaid or Medicare.
-
MD Anderson researchers find mechanisms behind CAR-T cells’ efficacy, toxicity
The findings may make it possible to identify a subset of patients who experience poorer outcomes or more serious side effects, especially neurotoxicity.
-
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology – currently in preclinical development – into human clinical trials. German drugmaker Bayer’s venture capital arm led the round.
-
Everlywell to launch at-home Covid-19 test Monday
The company said consumers can order the test for $135 and submit samples to CLIA-certified labs, with physicians providing free telehealth consultations if they test positive.
-
Bridge Patient Portal’s new version 3.0 makes publishing a client-branded mobile app affordable for healthcare organizations
Bridge Patient Portal v3.0 gives patients a seamless web-to-mobile experience for scheduling, messaging, bill pay, intake, medical records and more